MetaVia Inc - Company Profile
Powered by 
All the sales intelligence you need on MetaVia Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how MetaVia Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with MetaVia Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
The following section provides information on MetaVia Inc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into MetaVia Inc's management and employees, unlock the full data with our company analytics monitoring tool.
Executives
Andrew Koven
Chairman Executive BoardMr. Andrew Koven has been the Chairman of the company since 2021. Prior to this, he served as the President and Chief Business Officer of Aralez Pharmaceuticals Inc and the company’s predecessor at Pozen Inc. Previously, he served as the Executive Vice President, Chief Administrative Officer and General Counsel of Auxilium Pharmaceuticals Inc.
Hyung Heon Kim
President; Chief Executive Officer Senior ManagementMr. Hyung Heon Kim has been the Chief Executive Officer, President and Director of the company since 2023. Prior to this, he served as the General Counsel and Senior Vice President at Dong-A ST, where he was also a Director from 2018 to 2020. Previously, he served as the Head of International Legal Affairs at Dong-A Socio Holdings Co Ltd from 2012 to 2018.
Marshall Woodworth
Chief Financial Officer Senior ManagementMr. Marshall Woodworth has been the Chief Financial Officer of the company since March 2023. Prior to this, he served as the Chief Financial Officer of Nevakar Inc. Previously, he served as the Chief Financial Officer of Braeburn Pharmaceuticals Inc.
Mi-Kyung Kim
Chief Scientific Officer Senior ManagementMi-Kyung Kim is the Chief Scientific Officer of the company. Prior to this, she served as a Vice President, leading the overall new drug discovery research for metabolic and immune-mediated diseases at Dong-A ST. Previously, she has more than 25 years of experience in the pharmaceutical industry.
Robert Homolka
Senior Vice President - Clinical Operations Senior ManagementStill looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer